These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1514145)

  • 21. [Interaction between warfarin and oral miconazole gel].
    Ogard CG; Vestergaard H
    Ugeskr Laeger; 2000 Oct; 162(41):5511. PubMed ID: 11068529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on warfarin plasma concentration and its correlation with international normalized ratio.
    Sun S; Wang M; Su L; Li J; Li H; Gu D
    J Pharm Biomed Anal; 2006 Sep; 42(2):218-22. PubMed ID: 16860509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of benazepril, a converting enzyme inhibitor, on plasma levels and activity of acenocoumarol and warfarin.
    Van Hecken A; De Lepeleire I; Verbesselt R; Arnout J; Angehrn J; Youngberg C; De Schepper PJ
    Int J Clin Pharmacol Res; 1988; 8(5):315-9. PubMed ID: 3229872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fish oil interaction with warfarin.
    Buckley MS; Goff AD; Knapp WE
    Ann Pharmacother; 2004 Jan; 38(1):50-2. PubMed ID: 14742793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis.
    Pescatore P; Horellou HM; Conard J; Piffoux M; Van Dreden P; Ruskone-Fourmestraux A; Samama M
    Thromb Haemost; 1993 Apr; 69(4):311-5. PubMed ID: 8497841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Laboratory and therapeutic control of oral anticoagulant treatment].
    Salvetti E; Molinatti M
    Ann Osp Maria Vittoria Torino; 1987-1988; 30():67-71. PubMed ID: 3508666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The choice of an oral anticoagulant.
    Drug Ther Bull; 1972 Mar; 10(7):25-8. PubMed ID: 4114149
    [No Abstract]   [Full Text] [Related]  

  • 28. Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy.
    Sobieraj DM; Wang F; Kirton OC
    Pharmacotherapy; 2008 Dec; 28(12):1537-41. PubMed ID: 19025435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired warfarin resistance in a patient with mechanical heart valve].
    Gøtze JP; Thorsen S; Haunsø S
    Ugeskr Laeger; 2001 Dec; 163(50):7075-6. PubMed ID: 11794043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
    Warkentin TE; Whitlock RP; Teoh KH
    Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000; 38: 124-126.
    Muthukrishnan A
    Br J Oral Maxillofac Surg; 2002 Jun; 40(3):266. PubMed ID: 12054729
    [No Abstract]   [Full Text] [Related]  

  • 33. Intracranial bilateral vertebral artery dissection during anticoagulation after cerebral venous and sinus thrombosis (CSVT).
    Turowski B; Hanggi D; Siebler M
    Acta Neurochir (Wien); 2007 Aug; 149(8):793-7; discussion 797. PubMed ID: 17660937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)].
    Amián A; Rodríguez JN; Muñiz R; Diéguez JC; Moreno MV; Quesada JA; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
    Sangre (Barc); 1996 Feb; 41(1):9-11. PubMed ID: 8779047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial warfarin resistance.
    Holt RJ; Freytes CO
    Drug Intell Clin Pharm; 1983 Apr; 17(4):281-3. PubMed ID: 6839959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cluster-like headache due to warfarin therapy?
    Mainardi F; Maggioni F; Dainese F; Palestini C; Zanchin G
    Cephalalgia; 2003 Jul; 23(6):476-8. PubMed ID: 12807529
    [No Abstract]   [Full Text] [Related]  

  • 38. [Resistance to antivitamins K].
    Sánchez Villegas JM; Piqueras J; Nicolau I; Picó M; Soler JA; Monasterio J
    Sangre (Barc); 1992 Aug; 37(4):297-8. PubMed ID: 1514145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.